INVO Fertility (NASDAQ:IVF) reported quarterly losses of $(40.40) per share which missed the analyst consensus estimate of $(2.75) by 1369.09 percent. This is a 96.28 percent increase over losses of $(1.08 thousand) per share from the same period last year. The company reported quarterly sales of $1.583 million which missed the analyst consensus estimate of $1.927 million by 17.85 percent. This is a 6.11 percent decrease over sales of $1.686 million the same period last year.